Characterization of the Iatrogenic Drug Risk in Elderly Patients With Chronic Pain Who Consult the Pain Assessment and Treatment Centre at the Nimes University Hospital
- Conditions
- Iatrogenic Drug RiskChronic Pain
- Registration Number
- NCT04006444
- Lead Sponsor
- Centre Hospitalier Universitaire de Nīmes
- Brief Summary
Chronic pain may be an additional risk factor for drug iatrogeny due to its management and also drug non-compliance in the geriatric population.
it seems interesting to carry out an inventory of the iatrogenic risk before and after the consultation at the pain centre to enable us to identify the patients most at risk. This study would make it possible to characterize elderly patients with chronic pain, in order to consider, in a future study, setting up a pharmaceutical consultation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
- The patient must be affiliated or beneficiary of a health insurance
- Patient ≥ 65 years old
- Having an outpatient consultation at the pain centre of the Nîmes University hospital of for chronic pain
- Available for pharmaceutical consultation about 30 minutes
- It is impossible to give information
- The patient objects to participating in this study
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evolution of the ADE Geriatric risk score 2018 The score is calculated on 10 points based on 3 criteria : number of drugs prescribed, prescription of neuroleptics and the initiation of an anticoagulant prescription less than 3 months old. It classifies patients into 3 risk categories: a low risk level for a score of 0 to 1 point, a medium risk level for a score of 2 to 5 points and a high risk level for a score of 6 to 10 points.
- Secondary Outcome Measures
Name Time Method rate of patients with a low, medium or high risk level calculated by ADE Geriatric risk score according to the type of pain 2018 The score is calculated on 10 points based on 3 criteria : number of drugs prescribed, prescription of neuroleptics and the initiation of an anticoagulant prescription less than 3 months old. It classifies patients into 3 risk categories: a low risk level for a score of 0 to 1 point, a medium risk level for a score of 2 to 5 points and a high risk level for a score of 6 to 10 points.
Trial Locations
- Locations (1)
CHU Nimes
🇫🇷Nîmes, France